BioSig Technologies (NASDAQ:BSGM) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.
Analyst Recommendations
This is a breakdown of recent recommendations for BioSig Technologies and IRIDEX, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
BioSig Technologies | 0 | 0 | 0 | 0 | N/A |
IRIDEX | 0 | 0 | 2 | 0 | 3.00 |
IRIDEX has a consensus price target of $6.50, suggesting a potential downside of 8.19%. Given IRIDEX's higher possible upside, analysts clearly believe IRIDEX is more favorable than BioSig Technologies.
Volatility and Risk
BioSig Technologies has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.
Institutional & Insider Ownership
18.3% of BioSig Technologies shares are owned by institutional investors. Comparatively, 32.6% of IRIDEX shares are owned by institutional investors. 19.5% of BioSig Technologies shares are owned by company insiders. Comparatively, 2.0% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares BioSig Technologies and IRIDEX's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
BioSig Technologies | N/A | N/A | $-34,060,000.00 | N/A | N/A |
IRIDEX | $43.45 million | 2.53 | $-8,810,000.00 | ($0.64) | -11.05 |
IRIDEX has higher revenue and earnings than BioSig Technologies.
Profitability
This table compares BioSig Technologies and IRIDEX's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
BioSig Technologies | N/A | -244.64% | -213.88% |
IRIDEX | -21.54% | -38.60% | -24.99% |
Summary
IRIDEX beats BioSig Technologies on 7 of the 10 factors compared between the two stocks.